Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
03/14/2008
Trade Name:
NovoLog
Generic Name or Proper Name (*):
insulin aspart [rDNA origin] injection
Indications Studied:
Insulin analog indicated to improve glycemic control
Label Changes Summary:
Efficacy was demonstrated in a clinical study with pediatric patients ages 4 to 18 years using an external insulin pump New dosing regimen
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Novo Nordisk
NNPS:
FALSE'
Therapeutic Category:
Antidiabetic
-
-